Alzheimer Disease

1 protocols meet the specified criteria

OCR20352

ADvance II: A 12-month double-blind, randomized, controlled study to evaluate the safety and efficacy of Deep Brain Stimulation of the fornix (DBS-f) in patients with mild probable Alzheimer's Disease